Study Protocol: Adjuvant Holmium-166 Radioembolization After Radiofrequency Ablation in Early-Stage Hepatocellular Carcinoma Patients—A Dose-Finding Study (HORA EST HCC Trial)

PURPOSE: To investigate the biodistribution of holmium-166 microspheres ((166)Ho-MS) when administered after radiofrequency ablation (RFA) of early-stage hepatocellular carcinoma (HCC). The aim is to establish a perfused liver administration dose that results in a tumoricidal dose of holmium-166 on...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendriks, Pim, Rietbergen, Daphne D. D., van Erkel, Arian R., Coenraad, Minneke J., Arntz, Mark J., Bennink, Roel J., Braat, Andries E., Crobach, A. Stijn L. P., van Delden, Otto M., van der Hulle, Tom, Klümpen, Heinz-Josef, van der Meer, Rutger W., Nijsen, J. Frank W., van Rijswijk, Carla S. P., Roosen, Joey, Ruijter, Bastian N., Smit, Frits, Stam, Mette K., Takkenberg, R. Bart, Tushuizen, Maarten E., van Velden, Floris H. P., de Geus-Oei, Lioe-Fee, Burgmans, Mark C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307549/
https://www.ncbi.nlm.nih.gov/pubmed/35618860
http://dx.doi.org/10.1007/s00270-022-03162-7

Ejemplares similares

Ejemplares similares